From: Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant
Day of study* | - 2 | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | Â | 9 | Â | 14 | Â | 21 | 56 | 78 | 96 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Physical Exam | X | Â | X | X | X | X | X | X | X | X | X | X | X | ad | X | Â | Â | Â |
Shedding &Virema | X | Â | X | X | X | X | X | X | X | X | X | X | X | ad | X | Â | Â | Â |
SN titers | X | Â | Â | X | Â | Â | Â | Â | X | Â | Â | Â | X | Â | X | X | X | Â |
Nasal cytokines | X | Â | X | X | Â | Â | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Paxgene mRNA | X | Â | X | X | X | X | X | X | X | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Re-call responses: | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   -Prolif. | X |  |  |  |  |  | X |  | X |  |  |  |  |  | X | X | X | X |
   -Cytokines |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | X | X | X |